Application
Research Sub CategoryNuclear Receptors
Research CategoryEpigenetics & Nuclear Function
Immunocytochemistry Analysis: 4.0 µg/mL from a representative lot detected NUBP1 in HEK293 and HeLa cells.
Anti-NUBP1 Antibody | ABE1027 is an antibody against NUBP1 Antibody for use in Western Blotting, Immunocytochemistry.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
NUBP1 also known as NBP as is expressed in several tissues with the highest being in the lung and testis. NUBP1 appears to interact with actin and the cytoskeleton and is required for centrosome duplication but it is also need for proper synthesis of iron sulfur proteins and the protein also binds ATP. NUBP1 has roles in cell growth, cellular iron homeostasis, centrosome localization, iron-sulfur cluster assembly, and apolipoprotein modification. NUBP1 is localized to the cytoplasm. Interestingly too, recent research indicates that mutations in NUBP1 in mice lead defects in lung development and eye cataracts, many of which are traced back to NUBP1 role in regulating centrosome dynamics and microtubule organization.
Immunogen
Epitope: Unknown
KLH-conjugated linear peptide corresponding to human NUBP1.
Other Notes
Concentration: Please refer to lot specific datasheet.
Physical form
Affinity purified
Purified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Quality
Evaluated by Western Blotting in HeLa cell lysate.
Western Blotting Analysis: 1.0 µg/mL of this antibody detected NUBP1 in 10 µg of HeLa cell lysate.
Storage and Stability
Stable for 1 year at 2-8°C from date of receipt.
Target description
~35 kDa observed
This product has met the following criteria to qualify for the following awards: